Risk Factors for Endometrial Cancer among Women with a BRCA1 or BRCA2 Mutation: A Case Control Study

PURPOSE: BRCA mutation carriers may use tamoxifen for breast cancer prevention or treatment. Hormone replacement therapy is often prescribed after surgical menopause and oral contraceptives are recommended for ovarian cancer prevention. The objective of this study was to assess the impact of these m...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Fam Cancer
Päätekijät: Segev, Yakir, Rosen, Barry, Lubinski, Jan, Gronwald, Jacek, Lynch, Henry T., Moller, Pal, Kim-Sing, Charmaine, Ghadirian, Parviz, Karlan, Beth, Eng, Charis, Gilchrist, Dawna, Neuhausen, Susan L., Eisen, Andrea, Friedman, Eitan, Euhus, David, Ping, Sun, Narod, Steven A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4962606/
https://ncbi.nlm.nih.gov/pubmed/25838159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10689-015-9798-8
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia